Association of H2-blocker therapy and higher incidence of necrotizing enterocolitis: A case of excessive collateral damage?

Pediatrics

Volumn 117, Issue 2, 2006, Pages 531-532

  Patole, Sanjay ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; SUCRALFATE;

GESTATIONAL AGE; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; MORTALITY; NECROTIZING ENTEROCOLITIS; NOTE; PRIORITY JOURNAL; STOMACH PH; STOMACH ULCER; STRESS ULCER; CHEMICALLY INDUCED DISORDER; LOW BIRTH WEIGHT; NEWBORN; RISK FACTOR;

ENTEROCOLITIS, NECROTIZING; HISTAMINE H2 ANTAGONISTS; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; RISK FACTORS;

EID: 33644854410     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2005-2230     Document Type: Note

References (28)

1. Guillet R, Stoll BJ, Cotton CM, et al. Association of H2-blocker therapy and higher incidence of necrotizing enterocolitis in very low birth weight infants. Pediatrics. 2006;117(2). Available at: www.pediatrics.org/cgi/ content/full/117/2/e137
2. Walther FJ, Verloove-Vanhorick SP, Brand R, Ruys JH. A prospective survey of necrotising enterocolitis in very low birthweight infants. Paediatr Perinat Epidemiol. 1989;3:53-61
3. Chan KL, Saing H, Yung RW, Yeung YP, Tsoi NS. A study of pre-antibiotic bacteriology in 125 patients with necrotizing enterocolitis. Acta Paediatr Suppl. 1994;396:45-48
4. Stoll BJ. Epidemiology of necrotizing enterocolitis. Clin Perinatol. 1994;21:205-218
5. Tryba M. Role of acid suppressants in intensive care medicine. Best Pract Res Clin Gastroenterol. 2001;15:447-461
6. Ortiz JE, Sottile FD, Siegel P, Nasraway SA. Gastric colonization as a consequence of stress ulcer prophylaxis: a prospective, randomized trial. Pharmacotherapy. 1998;18:486-491
7. Tryba M, Cook DJ. Gastric alkalinization, pneumonia, and systemic infections: the controversy. Scand J Gastroenterol Suppl. 1995;210:53-59
8. Sing RF, Marino PL. A new perspective on stress ulcer prophylaxis. J Am Osteopath Assoc. 1992;92:1026-1027
9. Tryba M. The gastropulmonary route of infection: fact or fiction? Am J Med. 1991;91:135S-146S
10. Mazzacca G, Sabbatini F. Inhibition of gastric acid secretion: advantages and risks in short and long-term treatment. Ital J Gastroenterol. 1990;22(suppl 1):11-12
11. Triba M. Prevention of stress bleeding with ranitidine or pirenzepine and the risk of pneumonia. J Clin Anesth. 1988;1:12-20
12. Stockbruegger RW. Bacterial overgrowth as a consequence of reduced gastric acidity. Scand J Gastroenterol Suppl. 1985;111:7-16
13. Carrion V, Egan EA. Prevention of neonatal necrotizing enterocolitis. J Pediatr Gastroenterol Nutr. 1990;11:317-323
14. Kuusela AL, Ruuska T, Karikoski R, et al. A randomized, controlled study of prophylactic ranitidine in preventing stress-induced gastric mucosal lesions in neonatal intensive care unit patients. Crit Care Med. 1997;25:346-351
15. Lazzaroni M, Petrillo M, Tornaghi R, et al. Upper GI bleeding in healthy full-term infants: a case-control study. Am J Gastroenterol. 2002;97:89-94
16. Sarna MS, Saili A, Dutta AK, Sharma D. Stress associated gastric bleeding in newborn: role of ranitidine. Indian Pediatr. 1991;28:1305-1308
17. Agarwal AK, Saili A, Pandey KK, Saxena AK, Sarna MS, Dutta AK. Role of cimetidine in prevention and treatment of stress induced gastric bleeding in neonates. Indian Pediatr. 1990;27:465-469
18. Vandenplas Y, Scare L. The use of cimetidine in newborns. Am J Perinatol. 1987;4:131-133
19. Kuusela AL, Maki M, Ruuska T, Laippala P. Stress-induced gastric findings in critically ill newborn infants: frequency and risk factors. Intensive Care Med. 2000;26:1501-1506
20. Maki M, Ruuska T, Kuusela AL, Karikoski-Leo R, Ikonen RS. High prevalence of asymptomatic esophageal and gastric lesions in preterm infants in intensive care. Crit Care Med. 1993;21:1863-1867
21. Metz DC. Preventing the gastrointestinal consequences of stress-related mucosal disease. Curr Med Res Opin. 2005;21:11-18
22. Miller TA. Mechanisms of stress-related mucosal damage. Am J Med. 1987;83:8-14
23. Lulu DJ, Dragstedt LR 2nd. Massive bleeding due to acute hemorrhagic gastritis. Arch Surg. 1970;101:550-554
24. Kantorova I, Svoboda P, Scheer P, et al. Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial. Hepatogastroenterology. 2004;51:757-761
25. Cook DJ, Witt LG, Cook RJ, Guyatt GH. Stress ulcer prophylaxis in the critically ill: a meta-analysis. Am J Med. 1991;91:519-527
26. Tryba M. Prophylaxis of stress ulcer bleeding: a meta-analysis. J Clin Gastroenterol. 1991;13(suppl 2):S44-S55
27. Cothran DS, Borowitz SM, Sutphen JL, Dudley SM, Donowitz LG. Alteration of normal gastric flora in neonates receiving ranitidine. J Perinatol. 1997;17:383-388
28. MacLean LD. Prophylactic treatment of stress ulcers: first do no harm. Can J Surg. 1988;31:76-77